Bausch + Lomb Corporation announced the refinancing of its outstanding term B loans.
The company allocated a $2,802,125,000 tranche of new term B loans for this purpose.
The Replacement Term Loans will be used to refinance the Third Amendment Term Loans and the First Incremental Term Loans.
Refinancing Details
$2,802,125,000 tranche allocated to refinance outstanding term B loans with reduced margins.
Maturity Extension
Replacement Term Loans maturing on January 15, 2031, extending the maturity date from 2028.
Closure Timeline
Transactions expected to close in the first quarter of 2026, subject to completion uncertainties.
- The refinancing aims to lower borrowing costs and streamline debt obligations.
- Maturity extension provides Bausch + Lomb with a longer-term financing strategy.
The refinancing of term B loans demonstrates Bausch + Lomb's commitment to financial efficiency and long-term planning in the eye health industry.